T. Rowe Price Capital Appreciation Fund (PRWCX)
Back to Main Page

Capital Appreciation Fund (PRWCX)

About The Capital Appreciation Fund

The fund seeks long-term capital appreciation by investing primarily in common stocks. It may hold fixed-income and other securities to help preserve principal value.

David R. Giroux, CFA has managed this fund since 07/01/2006.

Because of the fund's fixed-income holdings or cash position, it may not keep pace in a rapidly rising market. And its value orientation carries the possibility that the market will not recognize a security's intrinsic worth for an unexpectedly long time or that a stock judged to be undervalued may actually be appropriately priced.

Asset Allocation as of 05/31/2016

Domestic Stock 57.3%
Domestic Bond 20.2%
Cash 15.6%
Foreign Bonds 4.4%
Foreign Stock 2.2%
Convertibles 1.0%
Preferreds 0.9%
Options -0.4%

10 Largest Holdings

Represents 26.52 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
Pfizer
Thermo Fisher Scientific
Tyco International
Willis Group Holdings
As of 05/31/2016 the Capital Appreciation Fund had a total of 269 holdings.

Good for...

Individuals seeking capital appreciation who can accept the price declines inherent in common stock investing but prefer a strategy that focuses on reducing risk as much as maximizing gains. Appropriate for both regular and tax-deferred accounts, such as IRAs.

Performance as of 03/31/2016

Average Annual Total Returns and Benchmarks

Average Annual Total Returns2

  Month End
5/31/16
Quarter End
3/31/16
1 Year 5.83% 4.21%
3 Years 11.26% 11.15%
5 Years 10.99% 10.84%
10 Years 8.75% 8.34%
Since Inception 11.37% 11.32%
Inception Date June 30, 1986
Expense Ratio as of 12/31/2015 0.70%
Current performance may be lower or higher than the quoted past performance, which cannot guarantee future results. Share price, principal value, and return will vary and you may have a gain or loss when you sell your shares.
2 Average annual total return figures include changes in principal value, reinvested dividends, and capital gain distributions. For funds less than one year old, the Since Inception return figure is not annualized and represents an aggregate total return.

Overall Morningstar Rating as of 04/30/20161

Morningstar rated the Capital Appreciation Fund among 817, 817, 695 and 464 Allocation--50% to 70% Equity funds for the overall rating and the 3-, 5-, and 10-year periods (as applicable) ending 04/30/2016, respectively. Morningstar Ratings™ are based on risk-adjusted returns. The Overall Morningstar Rating™ is derived from a weighted average of the performance figures associated with a fund's 3-, 5-, and 10-year (if applicable) Morningstar Rating™ metrics.

Ready to Prepare Your Portfolio?
1 For funds with at least a 3-year history, a Morningstar Rating™ is based on a risk-adjusted return measure (including the effects of sales charges, loads, and redemption fees) with emphasis on downward variations and consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% 4 stars, the next 35% 3 stars, the next 22.5% 2 stars, and the bottom 10% 1 star. Each share class is counted as a fraction of 1 fund within this scale and rated separately.
©2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.